C2321005

The Pfizer Clinical Research Unit is conducting a clinical trial with healthy volunteers to assess different forms of and the effect of food on an oral study drug for certain types of cancer.

The study drug is being evaluated for the treatment of specific cancers, including small cell lung cancer, prostate cancer, and lymphoma. Millions of people are diagnosed with these cancers every year. Affected patients are in need of effective and safe treatments, and healthy volunteers are an important part of developing these medicines.

Read more about this study below and see if you can make a difference as a healthy volunteer.

Card Summary Component

Who may participate

Clinical trials are key to developing potential life-changing treatments for people across the globe. But they can't happen without participants.

This study is seeking healthy adult volunteers, meaning that the participants will not have the condition being studied and are in overall good health. In addition to the criteria listed, participants must meet the following requirements: 

  • Willing to take a study drug
  • Willing and able to come to our facility in New Haven, CT*
  • Able to comply with all study procedures and appointments

*participants may be eligible to receive a bonus for travel, ask our staff for details

There are other requirements for participation in this study. The study staff will explain these to you during the screening process.

 

Do you know someone who may meet these requirements? Refer a friend and you may be eligible to receive a bonus.

Learn more
Condition

Healthy

Age

18+ years

Sex

All sexes

Referral bonus

Up to $100

Each clinical study has its own guidelines for who can participate, called eligibility criteria. However, only the research study staff can determine if you qualify to enroll in the study.

What to expect

If this study may be a fit for you, you’ll be invited to a screening visit at our facility in New Haven, CT. If you qualify for the study, there may be a period of up to 28 days before dosing.

If you choose to participate, you will stay at our facility for 13 consecutive overnights. You will be placed in one of two groups and receive one of the following:

  1. Starting the morning after admission, you will receive a single oral dose of the study drug every 5 days as 3 different oral formulations, for a total of up to 3 doses.
  2. Starting the morning after admission, you will receive a single oral dose of the study drug while fasted, with a low-fat meal, or with a high-fat meal, for a total of up to 3 doses.

You will receive one each of the above doses at least 7 days apart, given on an empty stomach and in a randomly chosen order, for a total of 3 dosing periods.

Throughout the study, staff will closely monitor your health status and collect data, such as the levels of the study drug in your blood.

 

Download informed consent form
Required overnight stays

13

Long-term follow up

1 phone call

How long is this study?

About 40 days

Compensation

Up to $4,600 upon completion of the study

All of the study procedures will be clearly explained to you during screening and can be viewed by downloading the informed consent form.

Interested in participating?

Complete and submit this form, and a Pfizer New Haven Clinical Research Unit (PCRU) representative will contact you. Please note: volunteers completing this form must be able to read and speak English at an 8th grade level.

You may also call 1-800-254-6398 and speak with a PCRU representative to learn more.

For Japanese language assistance only, please call 1-833-711-9984. We apologize, our representatives cannot take calls in languages other than English or Japanese at this time.

The personal data gathered here will be collected, processed, and maintained in a confidential manner. Your information will be stored in our research unit’s database. We may use this information to invite you to participate in current and future clinical studies at the PCRU. You will have full access to your records at the Pfizer New Haven Clinical Research Unit and the opportunity to correct them if necessary.

Cancel